Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 31 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shilpa Medicare's reported carbon emissions
In 2023, Shilpa Medicare reported total carbon emissions of approximately 15,000,350 kg CO2e, comprising 1,523,280 kg CO2e from Scope 1, 14,691,660 kg CO2e from Scope 2, and 710,410 kg CO2e from Scope 3 emissions. This represents a reduction in Scope 3 emissions from 877,770 kg CO2e in 2022, indicating a commitment to lowering their overall carbon footprint. For 2024, the company anticipates an increase in emissions, with Scope 1 emissions projected at 3,690,310 kg CO2e and Scope 2 emissions at 20,389,900 kg CO2e. Notably, Shilpa Medicare has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, suggesting a need for further commitment to climate action. Overall, while Shilpa Medicare has made strides in reducing certain emissions, particularly in Scope 3, the lack of formal reduction targets highlights an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,523,280 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,691,660 | 00,000,000 | 00,000,000 |
| Scope 3 | 877,770 | 000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
